Teacher Retirement System of Texas Acquires 63,939 Shares of Orthofix Medical Inc. (NASDAQ:OFIX)

Teacher Retirement System of Texas boosted its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 90.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,009 shares of the medical device company's stock after acquiring an additional 63,939 shares during the quarter. Teacher Retirement System of Texas owned 0.35% of Orthofix Medical worth $2,357,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. R Squared Ltd bought a new stake in shares of Orthofix Medical in the 4th quarter valued at about $50,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Orthofix Medical by 5.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,994 shares of the medical device company's stock valued at $156,000 after buying an additional 559 shares during the period. Quest Partners LLC lifted its position in shares of Orthofix Medical by 187.1% in the third quarter. Quest Partners LLC now owns 13,908 shares of the medical device company's stock valued at $217,000 after buying an additional 9,063 shares during the last quarter. Inceptionr LLC bought a new position in shares of Orthofix Medical during the 4th quarter worth approximately $279,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Orthofix Medical during the 3rd quarter worth approximately $270,000. Institutional investors and hedge funds own 89.76% of the company's stock.

Orthofix Medical Stock Performance

Shares of Orthofix Medical stock traded down $0.10 during trading on Friday, reaching $16.06. The company's stock had a trading volume of 150,950 shares, compared to its average volume of 258,356. The company has a quick ratio of 1.11, a current ratio of 2.39 and a debt-to-equity ratio of 0.25. The business's 50-day moving average price is $17.63 and its 200-day moving average price is $17.37. Orthofix Medical Inc. has a 52 week low of $12.08 and a 52 week high of $20.73. The firm has a market cap of $626.69 million, a PE ratio of -5.13 and a beta of 1.06.

Insider Activity

In other Orthofix Medical news, CEO Massimo Calafiore sold 9,203 shares of Orthofix Medical stock in a transaction on Monday, January 13th. The stock was sold at an average price of $17.14, for a total value of $157,739.42. Following the completion of the transaction, the chief executive officer now directly owns 124,151 shares of the company's stock, valued at $2,127,948.14. The trade was a 6.90 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Julie Andrews sold 4,655 shares of the company's stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $17.89, for a total value of $83,277.95. Following the sale, the chief financial officer now owns 28,312 shares of the company's stock, valued at approximately $506,501.68. The trade was a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 29,999 shares of company stock worth $512,497. Corporate insiders own 2.60% of the company's stock.

Analyst Ratings Changes

OFIX has been the subject of a number of research analyst reports. Canaccord Genuity Group reaffirmed a "buy" rating and set a $24.00 price objective on shares of Orthofix Medical in a research report on Wednesday, February 26th. StockNews.com raised shares of Orthofix Medical from a "hold" rating to a "buy" rating in a report on Tuesday, February 25th. Finally, Roth Mkm reiterated a "buy" rating and issued a $22.00 price target on shares of Orthofix Medical in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $23.33.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.